US › Healthcare

Qilian International Holding Group Limited (BGM)

US · Healthcare · Drug Manufacturers - Specialty & Generic

$8.65+0.70%

Last close · 2026-10-16

Latest quarter · ended 2026-03-31

Revenue

$24.3M

Net profit

$-2.1M

Net margin

-8.7%

Key statistics

Market cap

$127.5M

Forward P/E

0.0

P/B

0.26

Book value

$59.55

EPS (TTM)

$-4.47

52-week high

$303.00

52-week low

$6.45

50-day MA

$8.47

200-day MA

$25.48

Beta

1.46

Shareholding

Insiders

38.05%

Institutions

0.10%

Largest institutional holders

Fund	Stake
Geode Capital Management, LLC	0.05%
XTX Topco Ltd	0.03%
UBS Group AG	0.03%
Jane Street Group LLC	0.03%
Virtu Financial LLC	0.03%
Susquehanna International Group, LLP	0.02%
Ground Swell Capital, LLC	0.01%
JPMorgan Chase & Co	0.00%

Corporate actions

Action	Detail	Date
Split	1 : 30 effective Oct 1, 2026	2026-10-01

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Qilian International Holding Group Limited — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-10-19.